ASHLEY SCHOHN: Open Payments
NPI 1851709323 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,045 in 205 payments from 49 companies in 2025. Trend: 2023 $3,618 · 2024 $5,045 · 2025 $5,045
Food & beverage: $4,854Education: $191
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $575 |
| Janssen Biotech, Inc. | 16 | $407 |
| PFIZER INC. | 16 | $290 |
| Novartis Pharmaceuticals Corporation | 14 | $287 |
| Daiichi Sankyo Inc. | 10 | $227 |
| Merck Sharp & Dohme LLC | 8 | $218 |
| Incyte Corporation | 9 | $194 |
| ABBVIE INC. | 10 | $183 |
| GENZYME CORPORATION | 3 | $168 |
| TerSera Therapeutics LLC | 4 | $149 |
Products named: Enhertu, XTANDI, KEYTRUDA, Zoladex, ERLEADA, MONJUVI, REBLOZYL, Fabhalta.
Industry payments across AZ — which companies pay providers there.
